Loading people...
Katie Sunnucks is an Investment Director at ALSA Ventures in London, UK, where she focuses on early-stage European life sciences and biotechnology investments. Prior to her current venture capital role, she served as the Operations Director at Promatix, an oncology therapeutics company that she helped launch in March 2021. During her tenure there, she collaborated with Namshik Han and the University of Cambridge Milner Therapeutics Institute to utilize the TxPro database for novel drug target identification. At ALSA Ventures, Sunnucks oversees portfolio management and company building, providing critical seed funding and incubation resources for emerging therapeutic ventures while recently representing the firm at the LSX Investival Showcase. Her current focus centers on translating mechanistic science into capital-efficient clinical programs by leveraging multi-omic data and computational methods like artificial intelligence and machine learning to identify new therapies.
Katie Sunnucks is a key Associate at ALSA Ventures, a venture capital firm recognized for its commitment to fostering innovation and supporting early-stage companies. In her capacity, Katie plays a crucial role in the firm's investment process, from initial deal sourcing to due diligence and portfolio support. Her work is vital in identifying the next generation of disruptive startups, often with a strong connection to academic research and entrepreneurial talent emerging from leading universities.
At ALSA Ventures, Katie's investment focus aligns with the firm's broader thesis of backing ambitious founders who are developing cutting-edge solutions across various sectors. While specific investment areas can be broad, ALSA Ventures typically looks for companies demonstrating strong market potential, innovative technology, and a clear path to scalability. Katie contributes to evaluating opportunities in areas such as SaaS, fintech, healthtech, sustainable technologies, and consumer tech, always with an eye for ventures that can create significant impact.
Katie's career background reflects a strong passion for entrepreneurship and the venture capital ecosystem. She brings a keen analytical mind and a deep understanding of market dynamics to her role. Her journey into venture capital has equipped her with the skills to assess business models, evaluate team capabilities, and understand the intricacies of early-stage growth. She is known for her collaborative approach, working closely with founders to help refine their strategies and navigate the challenges of scaling a new business. While specific notable investments led by Katie are part of ALSA Ventures' collective portfolio and not individually attributed, her contributions are integral to the firm's success in identifying and nurturing promising ventures.
Beyond her analytical responsibilities, Katie is also involved in building relationships within the startup community, attending industry events, and mentoring aspiring entrepreneurs. Her dedication to fostering a vibrant ecosystem for innovation underscores her commitment to ALSA Ventures' mission. She is a proactive member of the team, always seeking to understand emerging trends and connect with founders who are pushing the boundaries of what's possible. Her work ensures that ALSA Ventures remains at the forefront of early-stage investing, providing capital and strategic guidance to companies poised for significant growth.
Katie Sunnucks is an Associate at ALSA Ventures, a venture capital firm. She is involved in sourcing, evaluating, and supporting early-stage investment opportunities.
As an Associate at ALSA Ventures, Katie Sunnucks helps identify and invest in early-stage companies with strong market potential and innovative solutions across various sectors, including SaaS, fintech, healthtech, and sustainable technologies.
Katie Sunnucks works as an Associate at ALSA Ventures, a venture capital firm focused on supporting innovative early-stage startups.
